Genetic Risk Prediction and a 2-Stage Risk Screening Strategy for Coronary Heart Disease
Author(s) -
Emmi Tikkanen,
Aki S. Havulinna,
Aarno Palotie,
Veikko Salomaa,
Samuli Ripatti
Publication year - 2013
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.112.301120
Subject(s) - medicine , interquartile range , framingham risk score , population , acute coronary syndrome , genetic testing , risk assessment , disease , genetic model , genetics , myocardial infarction , biology , computer security , environmental health , computer science , gene
Genome-wide association studies have identified several genetic variants associated with coronary heart disease (CHD). The aim of this study was to evaluate the genetic risk discrimination and reclassification and apply the results for a 2-stage population risk screening strategy for CHD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom